US 9487556
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
granted A61KA61K31/713A61P
Quick answer
US patent 9487556 (Polyconjugates for delivery of RNAi triggers to tumor cells in vivo) held by Arrowhead Pharmaceuticals, Inc. expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/713, A61P, A61P35/00, A61P43/00